β Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Stryker Corp
Healthcare & biotech / Orthopedics, medical and surgical, and neurotechnology and spine applications
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ§© Revenue Segmentation by Product
Switch to Location
Fiscal year | Segment | Value |
---|---|---|
2024 | MedSurg and Neurotechnology | 13.52B |
2024 | Orthopaedics | 9.08B |
2023 | MedSurg and Neurotechnology | 11.84B |
2023 | Orthopaedics | 8.66B |
2022 | MedSurg and Neurotechnology | 10.61B |
2022 | Orthopaedics | 7.84B |
2021 | MedSurg and Neurotechnology | 9.54B |
2021 | Orthopaedics | 7.57B |
2020 | MedSurg | 6.4B |

π° Explore more revenue segmentation data for Stryker Corp!
Sign up for free or log inπ₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"